FdaApplication
BLA 210605
Identifiers
- fda_app_no: BLA210605
Properties
| Property | Value |
|---|---|
| applicant_name | Mylan Pharmaceuticals Inc. |
| application_type | BLA |
| approval_date | 2020-06-11 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SEMGLEE | INSULIN GLARGINE | 1,000UNITS/10ML (100 UNITS/ML) | Injection |
| SEMGLEE | — | 300UNITS/3ML (100UNITS/ML) | Injection |
2 products